BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, December 18, 2024
See today's BioWorld
Home
» Novavax and Assembly lead infectious disease gainers in 2024
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Index insights
Novavax and Assembly lead infectious disease gainers in 2024
Nov. 26, 2024
By
Amanda Lanier
No Comments
The
BioWorld
Infectious Disease Index has struggled to gain ground in 2024 but has held relatively steady in recent months. After ending July down 7.66%, it closed October down 12.07% and sat at an 8.86% decline for the year as of Nov. 22.
BioWorld
Analysis and data insight
Infection